Suppr超能文献

趋化因子在中枢神经系统健康和病理学中的作用:以 CCL2/CCR2 和 CXCL8/CXCR2 网络为重点。

Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks.

机构信息

National Trauma Research Institute, Alfred Health, Melbourne, Victoria, Australia.

出版信息

J Cereb Blood Flow Metab. 2010 Mar;30(3):459-73. doi: 10.1038/jcbfm.2009.240. Epub 2009 Nov 11.

Abstract

Chemokines and their receptors have crucial roles in the trafficking of leukocytes, and are of particular interest in the context of the unique immune responses elicited in the central nervous system (CNS). The chemokine system CC ligand 2 (CCL2) with its receptor CC receptor 2 (CCR2), as well as the receptor CXCR2 and its multiple ligands CXCL1, CXCL2 and CXCL8, have been implicated in a wide range of neuropathologies, including trauma, ischemic injury and multiple sclerosis. This review aims to overview the current understanding of chemokines as mediators of leukocyte migration into the CNS under neuroinflammatory conditions. We will specifically focus on the involvement of two chemokine networks, namely CCL2/CCR2 and CXCL8/CXCR2, in promoting macrophage and neutrophil infiltration, respectively, into the lesioned parenchyma after focal traumatic brain injury. The constitutive brain expression of these chemokines and their receptors, including their recently identified roles in the modulation of neuroprotection, neurogenesis, and neurotransmission, will be discussed. In conclusion, the value of evidence obtained from the use of Ccl2- and Cxcr2-deficient mice will be reported, in the context of potential therapeutics inhibiting chemokine activity which are currently in clinical trial for various inflammatory diseases.

摘要

趋化因子及其受体在白细胞的迁移中起着至关重要的作用,在中枢神经系统(CNS)中引发的独特免疫反应方面尤其受到关注。趋化因子系统 CC 配体 2(CCL2)及其受体 CC 受体 2(CCR2),以及受体 CXCR2 及其多种配体 CXCL1、CXCL2 和 CXCL8,与广泛的神经病理学有关,包括创伤、缺血性损伤和多发性硬化症。这篇综述旨在概述趋化因子作为在神经炎症条件下白细胞迁移到中枢神经系统的介质的当前认识。我们将特别关注两种趋化因子网络,即 CCL2/CCR2 和 CXCL8/CXCR2,它们分别促进巨噬细胞和中性粒细胞浸润局灶性创伤性脑损伤后的损伤实质。这些趋化因子及其受体的组成性脑表达,包括它们在调节神经保护、神经发生和神经传递方面的新作用,将被讨论。总之,将报告使用 Ccl2-和 Cxcr2 缺陷型小鼠获得的证据的价值,这些证据与目前正在临床试验中用于各种炎症性疾病的抑制趋化因子活性的潜在治疗方法有关。

相似文献

9

引用本文的文献

本文引用的文献

8
Chemokine receptor antagonists: overcoming developmental hurdles.趋化因子受体拮抗剂:克服发育障碍
Nat Rev Drug Discov. 2009 Jan;8(1):23-33. doi: 10.1038/nrd2734. Epub 2008 Dec 12.
9
Monocyte chemoattractant protein-1: a key mediator in inflammatory processes.单核细胞趋化蛋白-1:炎症过程中的关键介质。
Int J Biochem Cell Biol. 2009 May;41(5):998-1001. doi: 10.1016/j.biocel.2008.07.018. Epub 2008 Aug 8.
10
Chemokines and neuromodulation.趋化因子与神经调节。
J Neuroimmunol. 2008 Jul 31;198(1-2):62-8. doi: 10.1016/j.jneuroim.2008.04.022. Epub 2008 Jun 9.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验